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Edited by Stuart FergusonAbstract Enediyne antibiotics are known for their potent
antitumor activities. One such enediyne, neocarzinostatin
(NCS), consists of a 1:1 complex of non-peptide chromophore
(1a), and peptide apoprotein. The structurally diverse non-
peptide chromophore is responsible for its biological activity.
One of its structural components, the naphthoic acid moiety (2,7-
dihydroxy-5-methyl-1-naphthoic acid, 1d) is synthesized by a
polyketide synthase (PKS) pathway through condensing six
intact acetate units. The 5.45 kb iterative type I PKS,
neocarzinostatin naphthoate synthase (NNS), responsible for
naphthoic acid moiety biosynthesis, shares sequence homology
with 6-methyl salicylic acid synthase of fungi and orsellinic acid
synthases (AviM and CalO5) of Streptomyces origin. Cultures
of S. lividans TK24 and S. coelicolor YU105 containing plasmids
with NNS were able to produce 2-hydroxy-5-methyl-1-naphthoic
acid (2a), a key intermediate of naphthoic acid moiety in NCS.
In addition to 2a, a novel product, 2-hydroxy-5-hydroxymethyl-
1-naphthoic acid (2d) was isolated. This is the ﬁrst report of a
bacterial iterative type I PKS from an enediyne producer which
enables the biosynthesis of bicyclic aromatic compounds.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Nature has provided a variety of structurally diverse poly-
ketides which have been used as valuable therapeutic agents.
Much interest has been taken in searching for and developing
novel polyketides of clinical signiﬁcance. Polyketides are bio-
synthetically derived from simple metabolites like acetates,
malonates, propionates, butyrates and their derivatives. Poly-* Corresponding author. Fax: +82-41-544-2919.
E-mail address: sohng@sunmoon.ac.kr (J.K. Sohng).
Abbreviations: 6-MSA(S), 6-methyl salicylic acid (synthase); ACP, acyl
carrier protein; AT, acyl transferase; DH, dehydratase; HPLC, high
performance liquid chromatography; KR, ketoreductase; KS, keto-
synthase; NCS, neocarzinostatin; NNS, neocarzinostatin naphthoate
synthase; ORF, open reading frame; PKS, polyketide synthase; TLC,
thin layer chromatography
0014-5793/$22.00  2004 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2004.04.033ketide synthase (PKS) catalyzes a decarboxylative condensa-
tion of these compounds into the growing polyketide chain.
Microbial PKSs are classiﬁed into three major types. A type I
PKS system consists of one or more multifunctional proteins
that contain a diﬀerent active site for each enzyme-catalyzed
reaction in polyketide carbon chain assembly and modiﬁcation
[1]. The macrolides of erythromycin and avermectin are ex-
amples of type I PKS products. Type II PKSs, on the other
hand, comprise sets of iteratively used individual proteins for
the production of multicyclic aromatic compounds (e.g., ac-
tinorhodin and tetrocenomycin) [2]. Type III PKSs are small
homodimer proteins that belong to the chalcone and stilbene
synthase superfamily [3]. Beside these typical PKS, there exists
a multifunctional monomodule PKS which catalyzes iterative
condensation of extenders in a polyketide chain. They belong
to a separate class, named as iterative type I PKS. The rep-
resentative examples are those involved in the biosynthesis of
6-methyl salicylic acid (6-MSA) in fungi (6-MSAS) [4] and
orsellinic acid synthase in bacteria (AviM) [5].
Enediynes, the most potent antitumor antibiotics known so
far, are also synthesized by a PKS pathway. They are char-
acterized by either a nine-membered bicyclo [7.3.0] dod-
ecadiynene or a ten-membered bicyclo [7.3.1] tridecadiynene
‘‘warhead’’ as a highly reactive core appended with aryl and
sugar moieties. The recent gene cluster cloning and identiﬁ-
cation of warhead PKS in the biosynthesis of C-1027 [6] and
calicheamicin [7] opened a new avenue for enediyne biosyn-
thesis research. Furthermore, analysis of putative gene clusters
from several enediyne producing actinomycetes, isolated by a
rapid PCR based genome scanning approach, shows a con-
served enediyne gene cassette including warhead PKS. It sug-
gests that biosynthesis of all enediyne warhead may proceed
via similar polyketide intermediates [8,9].
The chromophore of highly potent nine-membered neo-
carzinostatin (NCS) consists of four diﬀerent moieties, namely
the warhead (epoxybicyclo [7.3.0] dodecadienediyne), naph-
thoic acid, N-methyl fucosamine and an ethylene carbonate
unit (Fig. 1(a)). The chromophore is protected by non-covalent
binding within the apoprotein. The mechanism of chromo-
phore binding to apoprotein has been elucidated [10] and the
expression, characterization and functional identiﬁcation of
apoprotein have also been carried out [11]. Additionally,
the detailed mechanism of single- and double-stranded
DNA cleavage by NCS in vitro has been extensively investigated.ation of European Biochemical Societies.
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Fig. 1. Structurally diverse chromophore of: (a) NCS (b) kedarcidin (c) N1999A2 and (d) naphthoic acid moiety of NCS. Naphthoic moieties are
highlighted in red. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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and rearranges to form a bicyclic diradical that abstracts a
hydrogen atom from deoxyribose sugar rings [12,13]. Myers
et al. proved the role of sugar moiety as trivial in the speciﬁcity
towards DNA bases and proposed that the planar naphthoate
moiety (Fig. 1(d)) may have a crucial role [14]. On the other
hand, Goldberg and co-workers have proposed a model that
involves the intercalation of naphthoate moiety between bases
of DNA with simultaneous positioning of the warhead within
the minor groove, which then abstracts C-50 hydrogen via a
free-radical mechanism [15].
A 13C labeled feeding experiment proved that naphthoate
moiety is formed from six intact acetate units linked in head to
tail fashion [16]. Evidence from homology we report here of
neocarzinostatin naphthoate synthase (NNS) to 6-MSAS,
which is most extensively studied as iterative type I PKS [4,29]
involved in the biosynthesis of 6-MSA, leads us to predict
acetyl-CoA as the sole initiation unit and ﬁve malonyl-CoA
units as extenders that condense to give the products. Fur-
thermore, NNS shows homology to AviM involved in the
biosynthesis of orsellinic acid moiety in avilamycin [5] and to
CalO5 (an iterative type I PKS putatively involved in the
synthesis of aryl moiety in calicheamicin) [7]. Since 6-MSAS,
AviM and CalO5 are involved in the synthesis of monocyclic
aromatic compounds, the NNS involved in the biosynthesis of
bicyclic aromatic compounds is signiﬁcant. It is of interest to
understand and investigate the molecular basis of this very
unusual iterative type I PKS.
We cloned and sequenced an approximately about 33.0 kb
genomic DNA fragment of Streptomyces carzinostaticus in a
cosmid clone selected from screening. Analysis of the DNA
sequence revealed the presence of NNS along with some sugar
and accessory genes. In the course of the present work, BenShen and co-workers (Division of Pharmaceutical Science and
Department of Chemistry, University of Wisconsin-Madison,
US) also reported the gene cluster of NCS which was deposited
in GenBank under the accession number AY117439. Our se-
quence data are in full agreement. However, our analysis of the
position of the most probable ribosome binding site has caused
us to place the start codon of NNS 189 bp upstream from that
currently assigned in Genebank.
We describe here the cloning and functional identiﬁcation
of NNS by in vivo heterologous expression in S. lividans
TK24 and S. coelicolor YU105. The product isolation and
characterization resulted in two compounds, namely 2-
hydroxy-5-methyl-1-naphthoic acid (2a) and 2-hydroxy-5-
hydroxymethyl-1-naphthoic acid (2d). Compound 2a is a key
intermediate of naphthoic acid moiety of NCS, while 2d is a
shunt product probably produced by the action of some host
enzyme(s) upon primary metabolite 2a. This report represents
the ﬁrst isolation and characterization of naphthoate synthase
from enediyne producing Streptomyces.
Substituted naphthoate moieties are also found in some
other nine-membered enediynes like kedarcidin (Fig. 1(b))
produced from Streptoalloteichus sp. [17] and N1999A2
(Fig. 1(c)) produced from Streptomyces sp. AJ9493 [18], indi-
cating the possibility of ﬁnding NNS homology genes in them.2. Materials and methods
2.1. Bacterial strains and culture conditions
Streptomyces carzinostaticus ATCC 15944 was maintained on ISP2
agar plates. Genomic DNA was prepared after growing cells in YMB
medium at 28 C for three days. Escherichia coli XL1 Blue MRF was
used for gene manipulation and preparation of recombinant plasmids.
E. coli ET 12567/pUZ8002 was used as a host to prepare unmethylated
NNSO-MT A
6.0 kb from cosmid
E EPCRP
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Fig. 2. Strategy for cloning NNS into the expression vector pIRB25. E,
EcoRI; P, PstI; O-MT; A, ATP dependent adenylate/thioester-forming
enzyme.
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lividans TK24 and S. coelicolor YU105 were maintained on R2YE agar
plates at 28 C and for protoplast preparation the cells were grown into
YEME media with 5 mM MgCl2 and 0.5% Glycine at 28 C for 36 h.
For product isolation, S. lividans TK24 and S. coelicolor YU105
harboring the expression plasmids were cultivated in R2YE liquid
media. Ampicillin (100 lg/ml), thiostrepton (12.5, 50 lg/ml), and ap-
ramycin (100 lg/ml) were used for the selection.
2.2. Construction of genomic library and screening
Cloning and transformation of competent E. coli cells and in vitro
DNA manipulations were carried out according to the standard pro-
tocols [19]. Chromosomal DNA was isolated from S. carzinostaticus
after lysozyme treatment and phenol–chloroform extraction as de-
scribed by Hopwood and co-workers [20]. Then, it was partially di-
gested with Sau3A and fragments of 30 to 40-kb were ligated into the
cosmid vector pOJ446 (which had been digested withHpaI and BamHI
sites). The ligated products were packaged with Gigapack III XL
system (Stratagene, USA) and transduced into E. coli XL1 Blue MRF.
Primers were designed from the conserved region of dTDP-glucose 4,6-
dehydratase genes from several actinomycetes and NCS apoprotein
gene. The 340 bp DNA fragment corresponding to dTDP-D-glucose
4,6-dehydratase gene from the genome of S. carzinostaticus was
ampliﬁed using primers DW11 (upstream): 50-CACTTCGGGGGC-
GAGTCGCA CGT-30and DW32 (downstream): 50-GGGCCGT-
AGTTGTTCGAGCA-30. Similarly, 196 bp DNA fragment of NCS
apoprotein gene was ampliﬁed using the primers APO-1 (upstream): 50-
TGGGAATTCG CGGTGGTGCAGT-30and APO-2 (downstream):
50-GCAGATCTAGACCGCCTACGACG-30. These PCR products
were ligated into pGEM-3Zf()) vector, sequenced and taken as probes
for library screening. In hybridization experiments, the probes were
labeled with digoxigenin (DIG) using a DIG labeling and detection kit
(Boehringer, Mannheim, Germany) and puriﬁed by gel ﬁltration.
Hybridization was carried out for 6 h with each probe at 50 C in 10 ml
of 2 SSC [19]. Colony and Southern hybridization were performed
with Hybond N nylon membranes (Amersham, Braunschweig, Ger-
many) according to standard protocols. One cosmid clone, pNEO32,
that hybridized with both probes was further conﬁrmed by Southern
hybridizing with eryAII module-3 gene from Saccharopolyspora ery-
thraea and taken for sequencing.
2.3. DNA sequencing and computer analysis
Restriction enzyme digested DNA fragments of approximately 200–
3000-bp of pNEO32 were subcloned into pGEM3, pGEM7, and
pBluescript SK()) vectors. Sequencing was performed by the dide-
oxynucleotide chain termination method on automatic sequencer. The
DNASIS software package (version 2.1, 1995; Hitachi Software En-
gineering, San Bruno, CA) and BLAST (NCBI) were used for sequence
analysis and homology search in the GenBank database, respectively.
2.4. Construction of expression vector and plasmid
A high copy number expression vector pSE34, a derivative of
pWHM3 with bidirectional ermE* promoters [21], was modiﬁed by
destroying the EcoRI site and introducing a multiple cloning site
(MCS) towards one of the promotors. A new synthetic MCS was de-
signed using a pair of complimentary oligonucleotides 50-GAT-
CCCTGCAGTCTAGACCATGGGAATTCCTCGAAG-50, which
were annealed and cloned into BamHI/HindIII digested pSE34 vector
to create pIBR25. Whole NNS gene was cloned into pIBR25 in two
steps. The ﬁrst 558 bp were ampliﬁed from pNEO32 using primers BS1
(forward): 50-GTGCTGCAGACGGGCCGAATCTGTC-30 and BS2
(reverse): 50-GTCGTTGGAATTCGCGGCGG-30 (restriction sites
underlined). The PCR product was cloned into PstI/EcoRI digested
pIBR25 to form pNBS1. Then, 6.0 kb EcoRI fragment of the gene from
pNEO32 was inserted into the same site of pNBS1 to create pNBS2.
2.5. Protoplast preparation, transformation and screening
Polyethylene glycol mediated pNBS2 transformation into S. lividans
TK24 and S. coelicolor YU105 was carried out as described by Hop-
wood and co-workers [20]. The transformed host cells were regener-
ated on R2YE agar plates, overlaid with soft agar containing 12.5 lg/
ml of thiostrepton and screened on R2YE plates with 50 lg/ml thio-
strepton. Parallel transformation and screening were also carried out
with pIBR25.2.6. Extraction and isolation of the products formed by NNS
The hosts transformed with pNBS2 and pIBR25 were inoculated
into a 250 ml baﬄed ﬂask containing 50 ml R2YE liquid media with 50
lg/ml thiostrepton and grown at 28 C for 7 days. Then, whole content
was extracted with 100 ml ethyl acetate after adjusting pH to 3.5 using
1 M HCl. The organic phase was separated and evaporated under
vacuum. For preparative scale, 2000 ml culture media were used under
the same conditions.
2.7. Thin layer chromatography (TLC), ESI- MASS, high performance
liquid chromatography (HPLC) and NMR analysis
TLC of crude extract was carried out on aluminum silica plates
(25DC Alufolien, Kieselgel 90F254, MERCK, Germany) with MeOH/
CHCl3/C6H14/HCOOH (8:80:5:1) as a solvent. Developed plates were
charred with sulfuric acid reagent. The compounds were puriﬁed by
Silica column (Kieselgel 60, MERCK, Germany) chromatography
with a gradient elution of C6H14 and CHCl3 with 0–30% MeOH sol-
vent system. Further analysis was carried out by HPLC with a UV
detector at 260 nm. Mightysil RP-18, GP 250-4.5 (5 lm) column was
used in a linear gradient of 0–40% CH3CN in H2O at a ﬂow rate of 1.0
ml/min. The pure fractions collected from silica column were further
analyzed by ESI-MASS (Finnigan TSQ 7000 Mass Spectrometer).
Puriﬁed compounds were subjected to NMR spectroscopy (Varian,
FT-NMR 300 MHz, Unity Inova) after dissolving in DMSO-d6.3. Results
3.1. Cloning of biosynthetic gene cluster
On the assumption that the genes for the chromophore lie
adjacent to the gene for the apoprotein, we adopted a strategy
of using the NCS apoprotein as a probe to ﬁnd the biosyn-
thetic gene cluster of NCS. The dTDP-D-glucose 4,6-dehy-
dratase gene and type I PKS modular gene (eryAII) were also
used as probes. We have sequenced about 33.0 kb of a cosmid
clone (pNEO32) screened by three gene probes. A total of 33
open reading frames (ORFs) along with NNS were located in
pNEO32. The analysis revealed putative regulatory, transport,
structural, and unknown genes.
3.2. Sequence analysis of NNS
NNS shows homology with 6-MSAS, (38% identity), AviM
(43% identity) and CalO5 (45% identity). Interestingly, they
show almost identical domain to domain similarity to each
other. The gene has putative ATG as start and TAG as stop
codons, ﬂanked by genes for O-methyltransferase (O-MT) and
ATP-dependent adenylate/thioester-forming enzyme (A)
(Fig. 2). Comparative analysis of the acyl transferase (AT)
domain homology of NNS with other modular and iterative
type I PKS revealed an acetate speciﬁc signature. It contains the
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typical for binding selectivity of CoA esters of dicarboxylic acid
[22]. At the C-terminal, 100 amino acids downstream from the
active Ser, four other proposed invariant residues with con-
served Ala and His in the consensus motif 776AFHS779 are
identiﬁed. A Phe adjacent to a His residue is found to be crucial
for malonyl-CoA AT [23]. (It is Ser for methyl malonyl-CoA
AT and Gln for ethyl malonyl-CoA AT [24].) The ketosynthase
(KS) domain belongs to the thiolase family (Pfam: PF00108)
having N-terminal active site residue Cys228 in the consensus
motif of 225DTACAGAL232. Also, the His363=403 residues at C-
terminal are found as in other modular PKSs; histidines act as
general bases to increase the nucleophilicity of an active Cys
residue [23]. The C-terminal of NNS has a shorter acyl carrier
protein (ACP) with Ser1759 active site in a motif of
1755LGVDSVMTV1763 that binds phosphopantetheine, where
extenders attach. Unlike AviM and CalO5, it has a ketoreduc-
tase (KR) domain (1434–1614 amino acids) with a N-terminal
NADP(H) binding motif 1448GLGCLGLSVA1457 showing ho-
mology of 53% identity with that of 6-MSAS from P. patulum.
Since other modular PKSs have His, Gly and Pro active site
residues in conserved domain of the typeHXXXGXXXXP [25],
a region with the motif of 982HGLVGVEVTP991 between AT
and KR domains in NNS is assigned as a dehydratase (DH)
domain.
3.3. Cloning of NNS into an expression vector
It was not possible to clone the NNS gene into an expres-
sion vector in one step. Therefore, the ﬁrst few bps of the gene
were ampliﬁed with suitable restriction sites, and remaining
portion was taken directly from the cosmid (Fig. 2). The cor-
rect constructs were identiﬁed by restriction enzyme analysis.
3.4. TLC, ESI- MASS, HPLC and NMR analysis
After transformations, colonies which were morphologically
diﬀerent from wild type of hosts were observed. The sporula-
tion was completely diminished and a huge amount of brown
pigment was produced in agar plates. TLC of the crude extract
showed two distinct UV ﬂuorescent spots which were not
observed in the crude extract of control transformants con-
taining pIBR25. Silica gel column chromatography aﬀorded
12.0 mg/l of puriﬁed 2a and 7.0 mg/l of 2d. The HPLC proﬁle
of crude extract of transformants show the retention time of
50.3 min and 26.6 min, respectively (Fig. 3), for the com-Fig. 3. HPLC proﬁle of crude extract of pNBS2 transformants. 2a, 2-
Hydroxy-5-methyl-1-naphthoic acid; 2d, 2-hydroxy-5-hydroxymethyl-
1-naphthoic acid.pounds 2a and 2d under the conditions mentioned in Section
2.7. The assignment on HPLC proﬁle was further examined by
ESI-MASS spectrometry. The major molecular ion peaks at
201.2 (m=z) for 2a and 217.0 (m=z) for 2d were observed. Fi-
nally, they were characterized by 1H NMR and 13C NMR
spectroscopy.
2aNMR data. 13C NMR [(CD3)2SO, 75 MHz] d 172.48 (C-1
CO2H), 159.23 (C-2), 135.02 (C-5), 132.81 (C-4), 129.88 (C-9),
127.85 (C-7), 127.15 (C-10), 124.62 (C-6), 123.56 (C-3), 119.34
(C-1), 111.58 (C-8), 20.11 (C-5 Me). 1H NMR [(CD3)2SO, 300
MHz] d 2.66 (3H, s, Me-5), 7.16 (1H, d, J ¼ 7:00 Hz, H-6),
7.17 (1H, d, J ¼ 9:20 Hz, H-3), 7.37 (1H, q, 7.00/8.50 Hz, H-7),
8.02 (1H, d, 9.20 Hz, H-4), 8.37 (1H, d, J ¼ 8:60, H-8), 10.57
(1H, br s, OH-C2).
2d NMR data. 13C NMR [(CD3)2SO, 75 MHz] d 172.18 (C-
1, CO2H), 158.07 (C-2), 139.03 (C-5), 132.35 (C-4), 129.92 (C-
9), 127.89 (C-10), 125.95 (C-7), 124.38 (C-6), 122.73 (C-3),
119.08 (C-1), 111.73 (C-8), 62.13 (C5, CH2OH).
1H NMR
[(CD3)2SO, 300 MHz] d 4.90 (2H, s, –CH2 C5), 7.20 (1H, d,
J ¼ 9:20, H-3), 7.37 (1H, d, J ¼ 7:00, H-6), 7.40 (1H, q,
J ¼ 7:00=8:60, H-7), 8.12 (1H, d, J ¼ 9:20, H-4), 8.22 (1H, d,
J ¼ 8:37, H-8).4. Discussion
Biological activities of NCS are conserved in the chromo-
phore region. The naphthoate moiety has a crucial role as
described. Therefore, we sought to identify and characterize
the NNS responsible for the biosynthesis of the naphthoate
moiety. The sequence analysis shows homology with iterative
type I PKSs of fungal and bacterial origin. Considering the
consensus active motif of KS in modular and iterative type I
PKSs, KS of NNS shows diﬀerences in some amino acids
adjacent to active Cys residue (Fig. 4). Such diﬀerences may
have some signiﬁcance. Taking as an example of the evidence
from the X-ray crystal structure of type II KS (ZhuH) of
R1128 gene cluster [26], KS is responsible for controlling not
only the choice of substrates, but also for the extension of
polyketide chain. The side chains in several hydrophobic res-
idues of KS, that make a pocket for accommodating an acyl-
CoA chain, are determinants for controlling the carbon chain.
This may equally be true for NNS. However, the actual as-
signment of chain length control by KS domain will have to
await experimental veriﬁcation. The conserved extender
binding motif of ACP domain in NNS deviates from LGINS,PikKS1 (PikAI)   1277 -  VDTACSSSL  - 1285
TylKS1 (TylG)   1228 -  VDTACSSSL  - 1236
NysKS1 (NysB)     205  - VDTACSSSL -   213
OleKS1 (OleAI)     1219 -  VDTACSSSL  - 1227
AviM    192   -  IDTACSASL - 200
CalO5       178  -  VDTACSASL -  186
6-MSAS          199   -  VDAACASSL -  208
NNS      224 -  VDTACAGAL- 232
Fig. 4. Alignment of the conserved active site amino acids of KS do-
mains of various modular and iterative type I PKSs. KS1 represents
extender KS. Pik, pikromycin (AF079138); Tyl, tylosin (SFU78289);
Nys, nystatin (AF263912); Ole, oleandomycin (AAF82408); AviM,
PKS in avilamycin (AAK83194); CalO5, iterative type I PKS in cali-
cheamicin (AAM70355); 6-MSAS (P22367). Amino acids enclosed into
a box show the diﬀerence. Numbers represent position of amino acids.
B. Sthapit et al. / FEBS Letters 566 (2004) 201–206 205which is a typical case for most prokaryotes. Such deviation,
i.e., LGXDS, is also found in some modular systems of aver-
mectin [27] and candicidin biosynthesis [28].
As to the functional identiﬁcation of NNS, the expected
gene product 2,7-dihydroxy-5-methyl-1-naphthoic acid (2b)
was not isolated. Instead, 2a was recovered as a major product.
A biosynthetic pathway catalyzed by NNS is thus proposed
based on the production of the major compound synthesized
(Fig. 5). By reference to the well established biosynthetic
pathway of 6-MSAS from P. patulum [29,33], the ketoreduc-
tion and dehydration steps probably take place only after the
condensation of 2nd and 4th malonyl-CoA, yielding the single
hydroxylated product. It indicates that the hydroxylation at2b
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206 B. Sthapit et al. / FEBS Letters 566 (2004) 201–206The product synthesized by heterologously expressed PKS is
sometimes accompanied by extra product(s) modiﬁed in their
structure. They may be either intermediates or ﬂexible priming
products or products formed by the action of enzyme(s) in host
cell. The examples are the production of HU235 by the ex-
pression of PKS genes related to R1128 biosynthesis [31] and
pentaketide monocarboxylic acid production in the biosyn-
theis of 1,3,6,8-tetrahydroxynaphthalene by tetrahydroxy-
naphthalene synthase (T4HN) [32]. Production of the second
compound 2d is most likely by the action of a hydroxylase in
host cell upon the primary metabolite 2a. Though a probable
mechanism of 2d production cannot be given without experi-
mental evidence, it is appropriate to mention that the naph-
thoic acid moiety of N1999A2 (which is a nine membered
enediyne similar to NCS) has a –CH2OH group at the same
position C-5 [16] (Fig. 1(c)). Thus, NNS should share a com-
mon mechanism to that of naphthoate moiety biosynthesis in
N1999A2 for 2d production.
Clinical use of NCS is restricted by instability and sub-
stantial toxicity. To obtain a more stable form of NCS with
improved chemotherapeutic properties while retaining its bi-
ological activity is a challenge in NCS research. Alteration of
the structure of the naphthoic acid moiety may be a tool in
controlling such eﬀects, since it is predicted to be involved in
speciﬁcity of NCS action. Study of NNS at a molecular level
elucidates the iterative chain formation mechanism in this
novel enzyme. Engineering of it using a hybridization strategy
like domain swapping with the domains of other PKSs ac-
cepting diﬀerent kind of priming and extending units will
deﬁnitely lead to the production of modiﬁed NCS.
Recent studies on bacterial aromatic polyketide biosynthesis
are focused on altering product structure in several aspects like
primer unit incorporation, chain length and so on. Thus, using
the concept of combinatorial biosynthesis, a variety of novel
polyketides can be biosynthesized along with NNS. Further-
more, this work demonstrates a considerable promise in
identifying naphthoate moieties in the other case of enediyne
antibiotics mentioned above.Acknowledgements: This work was supported by the 21C Frontier
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